Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
B-cell lymphoma
Pharma
Autolus enters CAR-T race with FDA approval for Aucatzyl
Autolus is ready to hit the ground running with an FDA nod for its CD19 CAR-T Aucatzyl, a competitor to Gilead's Tecartus and Novartis' Kymriah.
Zoey Becker
Nov 11, 2024 11:30am
Roche guilty of serious marketing breach for Polivy website
Jul 14, 2023 9:40am
Gilead's Yescarta scoops up overall survival win
Mar 21, 2023 11:38am
NICE signs off on BeiGene's Brukinsa for blood cancer disorder
Sep 20, 2022 10:10am
BMS' CAR-T pressures Gilead in 2L lymphoma with broader nod
Jun 24, 2022 11:11pm
Novartis' CAR-T Kymriah posts impressive survival data in ALL
Jun 13, 2022 11:38am
